medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2006, Number 1

<< Back Next >>

Acta Med 2006; 4 (1)

Transplantation of progenitor hematopoietic cells in Mexico

Ruiz-Argüelles GJ, Gómez-Almaguer D

Language: Spanish
References: 35
Page: 25-28
PDF size: 56.52 Kb.


Text Extraction

No abstract


REFERENCES

  1. Sosa-Sánchez R, Córdova MS, Labardini JR, Chávez-Peón F. Trasplante de médula ósea en anemia aplástica. Reporte del primer caso en México. Rev Invest Clin Méx 1980; 32: 49-55.

  2. León-Rodríguez E, Sosa-Sánchez R, Gómez E, Ochoa-Sosa C. Bone marrow transplantation in aplastic anemia: experience at a Mexican institution. Rev Invest Clin Méx 1993; 45: 559-564.

  3. León-Rodríguez E, Sosa-Sánchez R. Bone marrow transplantation in Mexico. Report of the first successful graft in acute myeloblastic leukemia. Grupo de trasplante medular óseo del INNSZ. Rev Invest Clin Méx 1992; 44: 383-386.

  4. Morales-Polanco MR, Pizzuto-Chávez J. Bone marrow transplant in aplastic anemia. Current status and review of the first allogeneic transplants in Mexico. Gac Med Méx 1984; 120: 49-57.

  5. Delgado-Lamas JL, Garcés-Ruiz OM, Rubio-Jurado B. Hematopoietic cell transplantation: experience at the Western National Medical Center. Rev Invest Clin 2000; 52: 234-240.

  6. Vela-Ojeda J, Tripp-Villanueva F, Sánchez-Cortés E, Ayala-Sánchez M, Rosas-Cabral A, Esparza MG, García-Chávez J, García-León LD, González-Llaven J. Allogeneic bone marrow transplantation for chronic myeloid leukemia: a single center experience. Arch Med Res 2000; 31: 206-209.

  7. Reynoso-Gómez EE, Navarrete-Herrera Jr, Salinas-Rojas V, Sobrevilla-Calvo P, Miranda-López E. Experience with 22 bone marrow donors. Rev Invest Clin Méx 1997; 49: 465-468.

  8. Ruiz-Argüelles GJ, Gómez-Rangel D, Ruiz-Delgado GJ, Ruiz-Argüelles A, Pérez-Romano B, Rivadeneyra L. Results of an autologous non-cryopreserved, unmanipulated peripheral blood hematopoietic stem cell transplant program: a single institution, 10-year experience. Acta Haematologica 2003; 110: 179-183.

  9. Ruiz-Argüelles GJ, Lobato-Mendizábal E, Ruiz-Argüelles A, Pérez-Romano B, Arizpe-Bravo D, Marín-López A. Non-cryopreserved unmanipulated hematopoietic peripheral blood stem cell autotransplant program: Long term results. Arch Med Res 1999; 30: 380-384.

  10. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, Marín-López A, Larregina-Díez A, Apreza-Molina MG. Filgrastim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high-dose chemotherapy. Am J Hematol 1995; 48: 100-103.

  11. Ruiz-Argüelles GJ. Allogeneic stem cell transplantation using non-myeloablative conditioning regimens: Results of the Mexican approach. Int J Hematol 2002; 76(Suppl 1): 376-379.

  12. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Gómez-Almaguer D, López-Martínez B, Abreu-Díaz G, Bravo G, Jaime-Pérez JC. Features of the engraftment of allogeneic hematopoietic stem cells using reduced-intensity conditioning regimens. Leukemia Lymph 2001; 42: 145-150.

  13. Ruiz-Argüelles GJ, Gómez-Almaguer D, López-Martínez B, Ponce-de-León S, Cantú-Rodríguez OG, Jaime-Pérez JC. No cytomegalovirus-related deaths after non-ablative stem cell allografts. Hematology 2002; 7: 95-99.

  14. Ruiz-Argüelles GJ, Gómez-Rangel JD, Ponce-de-León S, González-Déctor L, Reyes-Núñez V, Garcés-Eisele J. The Mexican schedule to conduct allogeneic stem cell transplantation is related to a low risk of cytomegalovirus reactivation and disease. Am J Hematol 2003; In press.

  15. Ruiz-Argüelles GJ, López-Martínez B, Santellán-Olea MR, Abreu-Díaz G, Reyes-Núñez V, Ruiz-Argüelles A, Garcés-Eisele J. Follow up of hemopoietic chimerism in individuals given allogeneic hemopoietic stem cell allografts using an immunosuppressive, non-myeloablative conditioning regimen: a prospective study in a single institution. Leukemia Lymph 2002; 43: 1509-1511.

  16. Ruiz-Argüelles GJ, Gómez-Almaguer D, López-Martínez B, Cantú-Rodríguez OG, Jaime-Pérez JC, González-Llano O. Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia. Haematologica 2002; 87: 894-896.

  17. Ruiz-Argüelles GJ, Gómez-Almaguer D, Gómez Rancel JD, Vela-Ojeda J, Cantú-Rodríguez OG, Jaime-Pérez JC, González-Llano O, Herrera-Garza JL. Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute leukemia eligible for conventional allografting: a prospective study. Leukemia Lymph 2004; In press.

  18. Gómez-Almaguer D, Ruiz-Argüelles GJ, Tarín-Arzaga LC, González-Llano O, Jaime-Pérez JC, López-Martínez B, Cantú-Rodríguez OG, Herrera-Garza JL. Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience. Biol Blood Marrow Transpl 2003; 9: 157-161.

  19. Ruiz-Argüelles GJ, López-Martínez B, Gómez-Rangel D, Estrada E, Marín-López A, Bravo-Hernández G, Hernández JM. Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: a single institution experience. Hematology 2003; 8: 151-154.

  20. Gómez-Almaguer D, Ruiz-Argüelles GJ, Ruiz-Argüelles A, González-Llano O, Cantú OE, Hernández NE. Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis. Bone Marrow Transpl 2000; 25: 131-133.

  21. Ruiz-Argüelles GJ, Gómez-Almaguer D, Ruiz-Argüelles A, González-Llano O, Cantú OG, Jaime-Pérez JC. Results of an outpatient-based stem cell allotransplant program using non-myeloablative conditioning regimens. Am J Hematol 2001; 66: 241-244.

  22. Ruiz-Argüelles GJ, López-Martínez B, López-Ariza B. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed Hodgkin’s disease following autologous stem cell transplantation. Arch Med Res 2003; 34: 242-245.

  23. Ruiz-Argüelles GJ. The Mexican approach to conduct non-myeloablative stem cell transplantation. Eur J Haematol 2001; 67: 5-6.

  24. Gómez-Almaguer D. The simplification of the stem cell transplantation procedures in developing countries has resulted in cost-lowering and availability to more patients. Int J Hematol 2002: 76(Suppl 1): 380-382.

  25. Ruiz-Argüelles GJ, Gómez-Rangel D, Sánchez-Anzaldo J, Ruiz-Argüelles A, Porras-Ramírez G, Luis-López A. Trasplante de células de cordón umbilical: informe de dos casos. Medicina Univ 2002; 4: 233-235.

  26. Ruiz-Argüelles GJ, Reyes-Núñez V, Garcés-Eisele J, Warwick RM, McKenna L, Ruiz-Reyes G, Granados J, Mercado-Díaz MA. Acquired hemoglobin S trait in an adult patient with secondary acute myelogenous leukemia allografted with matched unrelated umbilical cord blood cells using a non-ablative conditioning regimen. Haema 2005; 8: 492-496.

  27. Ruiz-Argüelles GJ. Non-myeloablative bone marrow transplantation. Arch Med Res 2003; 34: 554-557.

  28. Ruiz-Argüelles GJ, Gómez-Almaguer D. Braking dogmata to help patients: Non-myeloablative hematopoietic stem cell transplantation. Expert Opin Biol Ther 2004; 4: 1693-1699.

  29. Ruiz-Argüelles GJ, López-Martínez B, Manzano C, Gómez-Rangel JD, Lobato-Mendizábal E. Significance of one human leukocyte antigen mismatch on outcome of non-myeloablative allogeneic stem cell transplantation from related donors using the Mexican schedule. Bone Marrow Transpl 2005; 35: 335-339.

  30. Gómez-Almaguer D, Ruiz-Argüelles GJ, Gutiérrez CH, Jaime-Pérez JC. Trasplante no mieloablativo de células progenitoras hematopoyéticas: Mitos y realidades. Rev Invest Clin Méx 2005; 57: 291-297.

  31. Ruiz-Argüelles GJ, Gómez-Almaguer D, Vela-Ojeda J, Morales-Toquero A, Gómez-Rangel JD, García-Ruiz-Esparza MA, López-Martínez B, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH. Extramedullary leukemic relapses following hematopoietic stem cell transplantation with non-myeloablative conditioning. Int J Hematol 2005; 82: 262-265.

  32. Ruiz-Argüelles GJ. The Mexican approach to conduct allogeneic stem cell transplantation: braking dogmata and facing the Matthew effect. Hematology 2005, 10 (Suppl 1):154-160.

  33. Ruiz-Argüelles GJ. Historia del trasplante de médula ósea en México. Rev Biomed 2005; 16: 207-213.

  34. Ruiz-Argüelles GJ, Gómez-Almaguer D, Tarín-Arzaga LC, Morales-Toquero A, Cantú-Rodríguez OG, Manzano C. Second allogeneic peripheral blood stem cell transplants with reduce-intensity conditioning. Rev Invest Clin Méx 2006; In press.

  35. Ruiz-Argüelles GJ, Gómez-Almaguer D. Nephrotic syndrome after non-myeloablative stem cell transplantation. Brit J Haematol 2006; In press.




2020     |     www.medigraphic.com